A Single Centre, Open-Label Study to Evaluate the Immunogenicity and Safety of Enzira Vaccine in Healthy Adults aged >= 18 to < 60 years and in Healthy Older Adults aged > 60 years for the 2007/2008 Northern Hemisphere Influenza Season.

Trial Profile

A Single Centre, Open-Label Study to Evaluate the Immunogenicity and Safety of Enzira Vaccine in Healthy Adults aged >= 18 to < 60 years and in Healthy Older Adults aged > 60 years for the 2007/2008 Northern Hemisphere Influenza Season.

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Oct 2013

At a glance

  • Drugs Influenza virus vaccine (Afluria) (Primary)
  • Indications Influenza virus infections
  • Focus Therapeutic Use
  • Sponsors CSL
  • Most Recent Events

    • 15 Mar 2012 Actual end date (22 Jun 2007) added as reported by European Clinical Trials Database.
    • 15 Mar 2012 Actual initiation date (17 May 2007) added as reported by European Clinical Trials Database.
    • 15 Mar 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top